Assays for N-terminus, C-terminus and mid-molecule parathyroid hormone have been assessed with respect to their sensitivity and specificity in the diagnosis of primary hyperparathyroidism (1° HPT). The mid-molecule assay was the most sensitive method studied and only failed to identify one out of 30 patients with histologically proven 1° HPT. In all three assays there was some degree of overlap between results observed in 1° HPT and in patients with non-parathyroid hypercalcaemia, with results in the latter group sometimes falling well within the hyperparathyroid range. This study highlights the limitations of currently available methods and emphasises the need for caution in the interpretation of parathyroid hormone (PTH) measurements.
References
1.
LucasPAWoodheadJS. The assessment of parathyroid function. In: HeathDAMarxSJ, eds. Calcium Disorders. London: Butterworth, 1982; 92–113.
2.
PapapoulosSEManningRMHendyGNStudies of circulating parathyroid hormone in man using a homologous amino-terminal specific immunoradiometric assay. Clinical Endocrinology1980; 13: 57–67.
3.
IngleARBaileyJEMatthewsHLHarropJS. Performance and clinical utility of a commercially available C-terminus PTH assay. Ann Clin Biochem1986; 23: 434–9.
4.
McCannDSKirkishLSThompsonNAn evaluation of RIA-kit technology for serum and plasma parathyroid hormone determinations. J Clin Immunoassay1986; 9: 193–202.
5.
ParthemoreJGRoosBAParkerDCAssessment of acute and chronic changes in parathyroid hormone secretion by a radioimmunoassay with predominant specificity for the carboxy-terminal region of the molecule. J Clin Endocrinol Metab1978; 47: 284–9.
6.
MarxSJSharpMEKrudyARadioimmunoassay for the middle region of human parathyroid hormone: studies with a radioiodinated synthetic peptide. J Clin Endocrinol Metab1981; 53: 76–84.
7.
MayerGPHabenerJFPottsJT. Parathyroid hormone secretion in vivo. Demonstration of a calcium-independent non-suppressible component of secretion. J Clin Invest1976; 57: 678–83.
8.
MayerGPKeatonJAHurstJGHabenerJF. Effects of plasma calcium concentration on the relative proportion of hormone and carboxyl fragment in parathyroid venous blood. Endocrinology1979; 104: 1778–84.
9.
MalletteLETumaSNBergerREKirklandJL. Radioimmunoassay for the middle region of human parathyroid hormone using an homologous antiserum with a carboxy terminal fragment of bovine parathyroid hormone as radioligand. J Clin Endocrinol Metab1982; 54: 1017–24.
10.
FreitagJMartinKJHruskaKImpaired parathyroid hormone metabolism in patients with chronic renal failure. N Engl J Med1978; 298: 29–32.
11.
RaiszLGYajnikCHBockmanRSBowerBF. Comparison of commercially available parathyroid hormone immunoassays in the differential diagnosis of hypercalcaemia due to primary hyperparathyroidism or malignancy. Ann Int Med1979; 91: 739–40.
12.
MundyGRIbbotsonKJD'SouzaSMThe hypercalcaemia of cancer. Clinical implications and pathogenic mechanisms. N Engl J Med1984; 310: 1719–27.
13.
MalletteLENammourH.False positive elevations of midregion parathyroid hormone: inhibition of radioligand binding by a heterophilic antibody in patient scrum. Abstract 134. IXth International Conference on Calcium Regulating Hormones and Bone Metabolism, 1986.
